Drugs that contain Telmisartan
1. Micardis patents expiration
MICARDIS's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5591762 | BOEHRINGER INGELHEIM | Benzimidazoles useful as angiotensin-11 antagonists |
Jan, 2014
(10 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5591762 | BOEHRINGER INGELHEIM | Benzimidazoles useful as angiotensin-11 antagonists |
Jan, 2014
(10 years ago) | |
| US6358986 | BOEHRINGER INGELHEIM | Polymorphs of telmisartan |
Jan, 2020
(4 years ago) | |
| US7998953 | BOEHRINGER INGELHEIM | Use of inhibitors of the renin-angiotensin system |
Jun, 2020
(3 years ago) | |
| US8003679 | BOEHRINGER INGELHEIM | Use of inhibitors of the renin-angiotensin system |
Oct, 2022
(1 year, 6 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-612) | Oct 16, 2012 |
Market Authorisation Date: 04 April, 2000
Treatment: Treatment of hypertension; Reduction of cardiac tissue damage associated with myocardial infarction; Treatment or prevention of stroke
Dosage: TABLET;ORAL
How can I launch a generic of MICARDIS before it's drug patent expiration?
More Information on Dosage
MICARDIS family patents
